EVERSANA is a proud sponsor and panelist of the 5th annual CAR-TCR Summit this September 11-13 in Boston, Massachusetts.
The summit brings together more than 1000 global leaders dedicated to innovating, developing and delivering CAR and TCR cell-based immunotherapies to patients across pharma, biotech, regulatory bodies, academia, and solution/service providers.
EVERSANA’s General Manager Seth Gordon is a panelist on “Ensuring CAR-TCR Therapies are Accessible to Patients,” on September 11 from 2:00-2:45pm.
The panel discussion will cover:
- The challenges faced when finalizing CAR-T reimbursement models
- How future allogeneic therapies will compare in reimbursement strategies
- The need to increase CAR-T sites to allow greater accessibility to care
Focused on the full end-to-end value chain from early research through to commercialization, the Summit features 150+ experts who will explore the innovations, developments, challenges, solutions, and present case studies across 6 dedicated tracks: discovery translation, clinical management, manufacturing, logistics, and commercialization.